RVMD - Revolution Medicines, Inc.
Price:
--
--
|
CONSENSUS:
Buy
DETAILS
|
PRICE TARGET:
$253.35
DETAILS
HIGH:
$320.00
LOW:
$179.00
MEDIAN:
$259.00
CONSENSUS:
$253.35
UPSIDE:
33.51%
Institutional Holders (13F)
| GURU | SHARES | VALUE | WEIGHT % | SHARES CHG | ACTION |
|---|---|---|---|---|---|
| Druckenmiller | 399,587 | $74.8M | 1.4% | +83,727 | INCREASED |
| Greenblatt | 120,702 | $22.6M | 0.1% | -5,199 | DECREASED |
| Cooperman | 35,500 | $6.6M | 0.0% | +10,500 | INCREASED |
| Wood | 20,300 | $3.8M | 0.0% | +17,700 | INCREASED |
Insider Trading
| DATE | INSIDER | TITLE | TYPE | SHARES | PRICE | VALUE |
|---|---|---|---|---|---|---|
| 2026-09-29 | Sandler Alan B. | officer: Chief Development Officer | SELL | 1,000 | $202.81 | $203K |
| 2026-09-29 | Sandler Alan B. | officer: Chief Development Officer | SELL | 1,199 | $203.91 | $244K |
| 2026-09-29 | Sandler Alan B. | officer: Chief Development Officer | SELL | 301 | $204.72 | $62K |
| 2026-09-29 | Sandler Alan B. | officer: Chief Development Officer | SELL | 2,200 | $200.82 | $442K |
| 2026-09-29 | Sandler Alan B. | officer: Chief Development Officer | SELL | 1,609 | $201.72 | $325K |
| 2026-09-29 | Sandler Alan B. | officer: Chief Development Officer | M-Exempt | 6,000 | $58.84 | $353K |
| 2026-09-25 | Cislini Jeff | officer: SVP & General Counsel | SELL | 765 | $207.32 | $159K |
| 2026-09-25 | Mancini Anthony | officer: See Remarks | SELL | 3,121 | $200.54 | $626K |
| 2026-09-24 | Mancini Anthony | officer: See Remarks | SELL | 587 | $200.00 | $117K |
| 2026-09-25 | Mancini Anthony | officer: See Remarks | M-Exempt | 3,121 | $33.62 | $105K |
| 2026-09-22 | ANDERSON ELIZABETH M | director | SELL | 910 | $191.85 | $175K |
| 2026-09-22 | ANDERSON ELIZABETH M | director | SELL | 4,985 | $192.54 | $960K |
| 2026-09-22 | ANDERSON ELIZABETH M | director | M-Exempt | 5,070 | $1.12 | $6K |
| 2026-09-22 | ANDERSON ELIZABETH M | director | SELL | 2,648 | $193.44 | $512K |
| 2026-09-22 | ANDERSON ELIZABETH M | director | SELL | 1,500 | $194.59 | $292K |
| 2026-09-22 | ANDERSON ELIZABETH M | director | SELL | 100 | $195.15 | $20K |
| 2026-09-18 | Mancini Anthony | officer: See Remarks | SELL | 1,764 | $196.94 | $347K |
| 2026-09-16 | Sandler Alan B. | officer: Chief Development Officer | SELL | 336 | $199.30 | $67K |
| 2026-09-16 | GOLDSMITH MARK A | director, officer: See Remarks | SELL | 13,775 | $199.30 | $2.7M |
| 2026-09-16 | Anders Jack | officer: Chief Financial Officer | SELL | 61 | $195.00 | $12K |
| 2026-09-16 | Cislini Jeff | officer: SVP & General Counsel | SELL | 52 | $195.01 | $10K |
| 2026-09-16 | Cislini Jeff | officer: SVP & General Counsel | SELL | 3,314 | $199.30 | $660K |
| 2026-09-16 | Mancini Anthony | officer: See Remarks | SELL | 1,747 | $199.30 | $348K |
| 2026-09-16 | Kelsey Stephen Michael | officer: See Remarks | SELL | 85 | $195.01 | $17K |
| 2026-09-16 | Kelsey Stephen Michael | officer: See Remarks | SELL | 5,484 | $199.30 | $1.1M |